| 1 |
Nan Y, Luo Q, Wu X, Chang W, Zhao P, Liu S, Liu Z. HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity. Mol Ther 2023;31:552-68. [PMID: 36245126 DOI: 10.1016/j.ymthe.2022.10.006] [Reference Citation Analysis]
|
| 2 |
Zheng S, Pan B. Multilevel data integration and molecular docking approach to systematically elucidate the underlying pharmacological mechanisms of Er-Zhi-Wan against hepatocellular carcinoma. Aging 2022. [DOI: 10.18632/aging.204369] [Reference Citation Analysis]
|
| 3 |
Han X, Lu J, Chen C, Deng Y, Pan M, Li Q, Wu H, Li Z, Ni B, Pandurangan A. Seven Hub Genes Predict the Prognosis of Hepatocellular Carcinoma and the Corresponding Competitive Endogenous RNA Network. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/3379330] [Reference Citation Analysis]
|
| 4 |
Fan J, Chen Y, Zhang W, Zhou X, Bai X, Chang C, Han Y, Liu J, Yang J. Identification of the Hub Genes and Potential Regulation Network in Chronic Hepatitis B via Bioinformatics Analysis. Disease Markers 2022;2022:1-12. [DOI: 10.1155/2022/6113807] [Reference Citation Analysis]
|
| 5 |
Xue C, Gu X, Bao Z, Su Y, Lu J, Li L. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment. Front Immunol 2022;13:847728. [PMID: 35281015 DOI: 10.3389/fimmu.2022.847728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 6 |
Wang C, Wang Y, Fu Z, Huang W, Yu Z, Wang J, Zheng K, Zhang S, Li S, Chen J. MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1. Front Oncol 2022;12:837581. [DOI: 10.3389/fonc.2022.837581] [Reference Citation Analysis]
|
| 7 |
Kodidela S, Behera A, Reddy ABM. Risk factors and clinical aspects associated with hepatocellular carcinoma: role of long noncoding RNAs. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma 2022. [DOI: 10.1016/b978-0-323-98806-3.00020-9] [Reference Citation Analysis]
|
| 8 |
Hu SP, Ge MX, Gao L, Jiang M, Hu KW. LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis. Cancer Cell Int 2021;21:686. [PMID: 34923990 DOI: 10.1186/s12935-021-02404-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Huang PS, Liao CJ, Huang YH, Yeh CT, Chen CY, Tang HC, Chang CC, Lin KH. Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer. Cancers (Basel) 2021;13:5361. [PMID: 34771525 DOI: 10.3390/cancers13215361] [Reference Citation Analysis]
|
| 10 |
Lu Q, Guo Q, Xin M, Lim C, Gamero AM, Gerhard GS, Yang L. LncRNA TP53TG1 Promotes the Growth and Migration of Hepatocellular Carcinoma Cells via Activation of ERK Signaling. Noncoding RNA 2021;7:52. [PMID: 34564314 DOI: 10.3390/ncrna7030052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
